Bioactive peptides: from preclinical to clinical studies
Protein hydrolysates exhibit significant potential in supporting metabolic and cardiovascular health and in modulating immune function. Their incorporation into food or pharmaceutical formulations requires the validation of these benefits through rigorous clinical trials.
Authors
- Beatriz Miralles (ORCID: https://orcid.org/0000-0003-4544-9074)
- Guillermo Santos‐Sánchez (ORCID: https://orcid.org/0000-0001-5790-2302)
- Marta Santos-Hernández (ORCID: https://orcid.org/0000-0003-0156-242X)
- Isidra Recio (ORCID: https://orcid.org/0000-0003-2973-5329)
Institutions
- University of Cambridge (GB)
- Instituto de Investigación en Ciencias de la Alimentación (ES)
- Addenbrooke's Hospital (GB)
- Universidad Autónoma de Madrid (ES)
Publication Details
- Journal
- Current Opinion in Clinical Nutrition & Metabolic Care
- Published
- 2025-10-03
- DOI
- https://doi.org/10.1097/mco.0000000000001177
- Primary Topic
- Protein Hydrolysis and Bioactive Peptides
- Type
- article
- Field-Weighted Citation Impact
- 0.00